科研之友
微信
新浪微博
Facebook
分享链接
摘要
Tadalafil and sildenafil are selective inhibitors of phosphodiesterase type 5, showing marked pharmacokinetic variability in patients with pulmonary arterial hypertension. It has been reported that sildenafil is a substrate for P-glycoprotein (P-gp), but whether tadalafil is a substrate for P-gp remains to be determined. The objective of the present study was to elucidate whether tadalafil is a substrate for P-gp. Transcellular transport of sildenafil and tadalafil (5 mu M each) was examined using renal epithelial LLC-PK1 and P-gpexpressing LLC-GA5-COL150 cell monolayers. The efflux ratio of the basal to apical (B to A) transport of sildenafil to the A to B transport after 120-min incubation in LLC-GA5-COL150 cells (1.52) was significantly higher than that in LLC-PK1 cells (0.711). The efflux ratio of the B to A transport of tadalafil to the A to B transport after 120 -min incubation in LLC-GA5-COL150 cells (10.4) was significantly higher than that in LLC-PK1 cells (1.23). In LLC-GA5-COL150 cell monolayers, the V-max and K-m values of sildenafil transport calculated from a modified Michaelis-Menten equation were 101 +/- 64pmol/min/cm(2) and 112 +/- 47 mu m, respectively. On the other hand, those of tadalafil transport were 13.6 +/- 4.8pmol/min/cm(2) and 22.7 +/- 9.3 mu m, respectively. In the presence of a P-gp inhibitor (PSC833), the B to A transport of tadalafil was decreased by 28.6% in LLC-GA5-COL150 cells, and the A to B transport of tadalafil was 6.59-fold greater than that in its absence. These results indicate that tadalafil is a substrate for P-gp.
- 出版日期2017-8
